Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Clinical Research

Active surveillance: Does serial prostate biopsy increase histological inflammation?

Prostate Cancer and Prostatic Diseases volume 16, pages 165–169 (2013)Cite this article

Subjects

Abstract

Background:

Active surveillance (AS) is an appropriate management strategy for men with low-risk prostate cancer. Most protocols recommend repeated prostate biopsy every 12–24 months. The purpose of this paper is to describe histological inflammation patterns in men on AS who underwent serial prostate biopsy for disease monitoring.

Methods:

We reviewed records of men on AS from January 1999 through February 2011 who had a diagnostic plus ⩾1 repeat transrectal ultrasound-guided biopsies performed at our institution. The type and degree of inflammatory infiltrate were grossly reviewed and scored for each patient’s biopsy by a single pathologist. Relationship of inflammation severity and number of serial biopsies was assessed using a repeated measures mixed model. Unpaired t-test and χ2-square analysis assessed variance in degree of inflammation and location of inflammation relative to cancer grade progression defined as Gleason sum increase.

Results:

Fifty-six men met study inclusion criteria. Mean age was 62.1 (6.5) years, 71% were stage cT1c, 79% had a PSA level <10 ng ml−1, and 98% had diagnostic Gleason sum ⩽6. A small, statistically significant increase in maximum chronic inflammation (CI) scores with greater number of repeat biopsies was observed. CI scores were not associated with number of biopsies based on upgrade status. The main limitation to our study is our small sample size. Potential unmeasured confounders, such as unreported antibiotic use or symptomatic prostatitis, may have also affected our findings.

Conclusions:

In this pilot study of 56 men on AS for localized prostate cancer, degree of chronic histological inflammation increased with greater number of prostate biopsies, but was not associated with subsequent risk of grade progression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Siegel R, Naishadham D, Jemal A . Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10–29.

    Article  PubMed  Google Scholar 

  2. Abouassaly R, Thompson IM, Platz EA, Klein EA . Epidemiology, Etiology, and Prevention of Prostate Cancer 10th edn vol. III: Chapter 95. Saunders: Philadephia, 2012; pp 2704–2705.

    Google Scholar 

  3. Cooperberg MR, Carroll PR, Klotz L . Active surveillance for prostate cancer: progress and promise. J Clin Oncol 2011; 29: 3669–3676.

    Article  PubMed  Google Scholar 

  4. Whitson JM, Porten SP, Hilton JF, Cowan JE, Perez N, Cooperberg MR et al. The relationship between prostate specific antigen change and biopsy progression in patients on active surveillance for prostate cancer. J Urol 2011; 185: 1656–1660.

    Article  PubMed  Google Scholar 

  5. Ross AE, Loeb S, Landis P, Partin AW, Epstein JI, Kettermann A et al. Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program. J Clin Oncol 2010; 28: 2810–2816.

    Article  CAS  PubMed  Google Scholar 

  6. Raaijmakers R, Kirkels WJ, Roobol MJ, Wildhagen MF, Schrder FH . Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 2002; 60: 826–830.

    Article  PubMed  Google Scholar 

  7. Shigehara K, Miyagi T, Nakashima T, Shimamura M . Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis. J Infect Chemother 2008; 14: 40–43.

    Article  PubMed  Google Scholar 

  8. Fujita K, Landis P, McNeil BK, Pavlovich CP . Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance. J Urol 2009; 182: 2664–2669.

    Article  PubMed  Google Scholar 

  9. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, Drake CG et al. Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007; 7: 256–269.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. MacLennan GT, Eisenberg R, Fleshman RL, Taylor JM, Fu P, Resnick MI et al. The influence of chronic inflammation in prostatic carcinogenesis: a 5-year followup study. J Urol 2006; 176: 1012–1016.

    Article  PubMed  Google Scholar 

  11. Bassett WW, Bettendorf DM, Lewis JM, Loughlin KR . Chronic periglandular inflammation on prostate needle biopsy does not increase the likelihood of cancer on subsequent biopsy. Urology 2009; 73: 845–849.

    Article  PubMed  Google Scholar 

  12. Terakawa T, Miyake H, Kanomata N, Kumano M, Takenaka A, Fujisawao M . Inverse association between histologic inflammation in needle biopsy specimens and prostate cancer in men with serum PSA of 10-50 ng/mL. Urology 2008; 72: 1194–1197.

    Article  PubMed  Google Scholar 

  13. Delongchamps NB, de la Roza G, Chandan V, Jones R, Sunheimer R, Threatte G et al. Evaluation of prostatitis in autopsied prostates--is chronic inflammation more associated with benign prostatic hyperplasia or cancer? J Urol 2008; 179: 1736–1740.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Karakiewicz PI, Benayoun S, Begin LR, Duclos A, Valiquette L, McCormack M et al. Chronic inflammation is negatively associated with prostate cancer and high-grade prostatic intraepithelial neoplasia on needle biopsy. Int J Clin Pract 2007; 61: 425–430.

    Article  CAS  PubMed  Google Scholar 

  15. Wang W, Bergh A, Damber JE . Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate. Prostate 2009; 69: 1378–1386.

    Article  PubMed  Google Scholar 

  16. Fleshner NE, Klotz LH . Diet, androgens, oxidative stress and prostate cancer susceptibility. Cancer Metastasis Rev 1998; 17: 325–330.

    Article  CAS  PubMed  Google Scholar 

  17. Janeway CA, Medzhitov R . Innate immune recognition. Annu Rev Immunol 2002; 20: 197–216.

    Article  CAS  PubMed  Google Scholar 

  18. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004; 431: 461–466.

    Article  CAS  PubMed  Google Scholar 

  19. Nickel JC, True LD, Krieger JN, Berger RE, Boag AH, Young ID . Consensus development of a histopathological classification system for chronic prostatic inflammation. BJU Int 2001; 87: 797–805.

    Article  CAS  PubMed  Google Scholar 

  20. Fujita K, Hosomi M, Tanigawa G, Okumi M, Fushimi H, Yamaguchi S . Prostatic inflammation detected in initial biopsy specimens and urinary pyuria are predictors of negative repeat prostate biopsy. J Urol 2011; 185: 1722–1727.

    Article  PubMed  Google Scholar 

  21. Nickel JC, Roehrborn CG, O’Leary MP, Bostwick DG, Somerville MC, Rittmaster RS . The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial. Eur Urol 2008; 54: 1379–1384.

    Article  PubMed  Google Scholar 

  22. Kryvenko ON, Jankowski M, Chitale DA, Tang D, Rundle A, Trudeau S et al. Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer. Mod Pathol 2012; 25: 1023–1032.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Dall’Era MA, Konety BR . Active surveillance for low-risk prostate cancer: selection of patients and predictors of progression. Nat Clin Pract Urol 2008; 5: 277–283.

    Article  PubMed  Google Scholar 

  24. Cooperberg MR, Cowan JE, Hilton JF, Reese AC, Zaid HB, Porten SP et al. Outcomes of active surveillance for men with intermediate-risk prostate cancer. J Clin Oncol 2011; 29: 228–234.

    Article  PubMed  Google Scholar 

  25. Gerstenbluth RE, Seftel AD, MacLennan GT, Rao RN, Corty EW, Ferguson K et al. Distribution of chronic prostatitis in radical prostatectomy specimens with up-regulation of bcl-2 in areas of inflammation. J Urol 2002; 167: 2267–2270.

    Article  PubMed  Google Scholar 

  26. Karin M . NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol 2009; 1: a000141.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Karin M, Cao Y, Greten FR, Li ZW . NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002; 2: 301–310.

    Article  CAS  PubMed  Google Scholar 

  28. Ammirante M, Luo JL, Grivennikov S, Nedospasov S, Karin M . B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature 2010; 464: 302–305.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Luo JL, Tan W, Ricono JM, Korchynskyi O, Zhang M, Gonias SL et al. Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin. Nature 2007; 446: 690–694.

    Article  CAS  PubMed  Google Scholar 

  30. Patel AR, Jones JS, Rabets J, DeOreo G, Zippe CD . Parasagittal biopsies add minimal information in repeat saturation prostate biopsy. Urology 2004; 63: 87–89.

    Article  PubMed  Google Scholar 

  31. Porten SP, Whitson JM, Cowan JE, Cooperberg MR, Shinohara K, Perez N et al. Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance. J Clin Oncol 2011; 29: 2795–2800.

    Article  PubMed  Google Scholar 

  32. Nelson WG, De Marzo AM, DeWeese TL, Isaacs WB . The role of inflammation in the pathogenesis of prostate cancer. J Urol 2004; 172: S6–11 discussion S11-12.

    Article  CAS  PubMed  Google Scholar 

  33. Kramer G, Mitteregger D, Marberger M . Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol 2007; 51: 1202–1216.

    Article  CAS  PubMed  Google Scholar 

  34. Sciarra A, Di Silverio F, Salciccia S, Autran Gomez AM, Gentilucci A, Gentile V . Inflammation and chronic prostatic diseases: evidence for a link? Eur Urol 2007; 52: 964–972.

    Article  CAS  PubMed  Google Scholar 

  35. Roehrborn CG . Definition of at-risk patients: baseline variables. BJU Int 2006; 97 (Suppl 2): 7–11 discussion 21–12.

    Article  PubMed  Google Scholar 

  36. Schatteman PH, Hoekx L, Wyndaele JJ, Jeuris W, Van Marck E . Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density. Eur Urol 2000; 37: 404–412.

    Article  CAS  PubMed  Google Scholar 

  37. Stimac G, Reljic A, Spajic B, Dimanovski J, Ruzic B, Ulamec M et al. Aggressiveness of inflammation in histological prostatitis--correlation with total and free prostate specific antigen levels in men with biochemical criteria for prostate biopsy. Scott Med J 2009; 54: 8–12.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, University of California, San Francisco, CA, USA

    A S Glass, S P Porten, M Bonham, T C Tran, J E Cowan, S Punnen, J M Chan & P R Carroll

  2. Department of Pathology, University of California, San Francisco, CA, USA

    M Bonham

  3. Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA

    S Punnen & P R Carroll

  4. Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA

    J M Chan

Authors
  1. A S Glass
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S P Porten
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Bonham
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T C Tran
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J E Cowan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S Punnen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J M Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. P R Carroll
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A S Glass.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Glass, A., Porten, S., Bonham, M. et al. Active surveillance: Does serial prostate biopsy increase histological inflammation?. Prostate Cancer Prostatic Dis 16, 165–169 (2013). https://doi.org/10.1038/pcan.2012.51

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/pcan.2012.51

Keywords

This article is cited by

Search

Advanced search

Quick links